Please Find Attached herewith intimation regarding update on Acquisition.
M&A
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 17 Jul 2026, 06:10 PM IST · BSE ID: b8e48139-a4c5-4249-9c4c-c1db790990ad
View Original BSE Filing (PDF)
💡
In Simple Terms
Alkem Laboratories' subsidiary has finished buying a 51% to 55% stake in Swiss company Occlutech Holding AG.
🤖 AI Summary
- Alkem Medtech Private Limited completed the acquisition of 51% to 55% of Occlutech Holding AG's equity share capital.
- Occlutech Holding AG, a Switzerland-incorporated company, is now a step-down subsidiary of Alkem Laboratories Ltd.
- This completion follows previous intimations dated February 13, March 6, and June 29, 2026.
- Alkem Medtech Private Limited is a wholly owned subsidiary of Alkem Laboratories Ltd in India.
🏢 How This Affects the Company
The acquisition integrates Occlutech Holding AG into Alkem Laboratories' operational structure, expanding its reach into new markets or product segments. Occlutech Holding AG now contributes to the overall business portfolio and strategic direction.
Occlutech Holding AG's financial results will be consolidated into Alkem Laboratories' statements as a step-down subsidiary. This includes its revenue, expenses, and assets impacting the consolidated balance sheet and income statement.
Alkem Laboratories gains operational control and integrates Occlutech Holding AG's processes and resources. This includes managing its workforce, supply chain, and production capacities as part of the broader group.
The acquisition introduces risks associated with integrating a foreign entity, including operational, regulatory, and market risks specific to Switzerland and Occlutech's business. Management must navigate cultural differences and market dynamics.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this acquisition completion update.
👤
Who Is Affected
Shareholders of Alkem Laboratories Ltd are indirectly affected as the company's consolidated business portfolio now includes Occlutech Holding AG as a step-down subsidiary, potentially altering future financial metrics.
🔍
Management Signal
The completion signals management's commitment to executing its announced strategic acquisition plans and expanding the company's global footprint.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Alkem Laboratories' next quarterly results — assess initial integration and contribution from Occlutech.
Future management commentary on Occlutech's operational performance and strategic fit.
Regulatory updates regarding international business operations post-acquisition.
MEDIUM RISK
Integrating a foreign subsidiary involves operational and regulatory challenges, and the acquisition value was not disclosed in the filing.
💡 Investor Takeaway
Alkem Medtech Private Limited has completed its acquisition of 51% to 55% of Occlutech Holding AG, a Switzerland-incorporated company. Occlutech is now a step-down subsidiary of Alkem Laboratories, confirming the strategic expansion as previously intimated.
⚖️ Strengths & Concerns
✅ Positives
- Completion of the acquisition enhances Alkem Laboratories' business scope by incorporating Occlutech Holding AG as a step-down subsidiary.
- The 51%-55% ownership stake provides Alkem Medtech Private Limited with significant control over Occlutech Holding AG's operations and strategy.
📅 Company Track Record
Alkem Laboratories' subsidiary, Alkem Medtech, had previously disclosed its intention to acquire 51%-55% of Occlutech Holding AG, with earlier intimations on February 13, March 6, and June 29, 2026. The June 29, 2026 filing indicated a supplementary agreement was executed for this acquisition.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What is the status of Alkem Laboratories' acquisition of Occlutech Holding AG?
The acquisition of at least 51% and up to 55% of Occlutech Holding AG by Alkem Medtech Private Limited stands completed pursuant to the Share Purchase Agreement.
Which entity within Alkem Laboratories completed the acquisition?
M/s. Alkem Medtech Private Limited, a wholly owned subsidiary of Alkem Laboratories Limited in India, completed the acquisition.
What is the new relationship between Alkem Laboratories and Occlutech Holding AG?
Occlutech Holding AG, a company incorporated in Switzerland, will now be a step-down subsidiary of Alkem Laboratories Limited.
What stake did Alkem Medtech Private Limited acquire in Occlutech Holding AG?
Alkem Medtech Private Limited acquired at least 51% and up to 55% of the total issued equity share capital of Occlutech Holding AG.
Questions based on this BSE filing only. For information purposes.